首页> 外文期刊>Brain research bulletin >Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat
【24h】

Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat

机译:诺比列汀通过激活p-Akt,p-CREB,BDNF和Bcl-2途径并改善大鼠的血脑屏障通透性来预防脑缺血

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

There is cumulative evidence that the serine-threonine kinase Akt and its downstream nuclear transcription factor CREB are involved in neuronal survival and protection. The Akt activates and phosphorylates CREB at Ser133, resulting in the up-regulation of pro-survival CREB target genes such as BDNF and Bcl-2. Thus, Akt/CREB signaling pathway may be one propitious target for treatment of ischemic cerebral injury. Nobiletin (NOB) exhibits a wide spectrum of beneficial biological properties including anti-inflammatory, antioxidant, anti-carcinogenic actions and contributes to reverse learning impairment in Alzheimer's disease rat. However, little is currently known regarding the exact role of NOB in ischemic stroke. Here, we designed to evaluate its possible therapeutic effect on cerebral ischemia. Adult male Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion (pMCAO) and randomly divided into five groups: Sham (sham-operated. + 0.05% Tween-80), MCAO (pMCAO + 0.9% saline), Vehicle group (pMCAO + 0.05% Tween-80), NOB-L (pMCAO + NOB 10. mg/kg) and NOB-H (pMCAO + NOB 25. mg/kg) groups. Rats were pre-administered intraperitoneally once daily for 3 days before surgery and then received once again immediately after surgery. Neurological deficit scores, brain water content and infarct volume were evaluated at 24. h after stroke. Additionally, the activities of Akt, CREB, BDNF, Bcl-2 and claudin-5 in ischemic brain cortex were analyzed by the methods of immunohistochemistry, western blot and RT-qPCR. Compared with Vehicle group, neurological deficits and brain edema were relieved in NOB-H group ( P < 0.05), infarct volume was lessened in both NOB-L and NOB-H groups ( P < 0.05) at 24. h after stroke. Immunohistochemistry, western blot and RT-qPCR analysis indicated that NOB dramatically promoted the activities of Akt, CREB, BDNF and Bcl-2 ( P < 0.05). Meanwhile, claudin-5 expression was also enhanced. On the basis of these findings, we concluded that NOB protected the brain from ischemic damage and it maybe through activating the Akt/CREB signaling pathway and ameliorating BBB permeability.
机译:有累积的证据表明,丝氨酸-苏氨酸激酶Akt及其下游核转录因子CREB参与神经元的存活和保护。 Akt激活CR133处的CREB并使其磷酸化,从而导致生存前CREB靶基因(如BDNF和Bcl-2)的上调。因此,Akt / CREB信号通路可能是治疗缺血性脑损伤的一种有利靶标。 Nobiletin(NOB)具有广泛的有益生物学特性,包括抗炎,抗氧化,抗癌作用,并且有助于阿尔茨海默氏病大鼠的逆向学习障碍。然而,关于NOB在缺血性中风中的确切作用目前知之甚少。在这里,我们设计以评估其对脑缺血的可能治疗作用。成年雄性Sprague-Dawley大鼠经历永久性大脑中动脉闭塞(pMCAO),随机分为五组:假手术(假手术+ 0.05%Tween-80),MCAO(pMCAO + 0.9%生理盐水),媒介物组( pMCAO + 0.05%Tween-80),NOB-L(pMCAO + NOB 10. mg / kg)和NOB-H(pMCAO + NOB 25. mg / kg)组。在手术前3天每天对大鼠进行一次腹膜内给药,然后在手术后立即再次给药。脑卒中后24小时评估神经功能缺损评分,脑含水量和梗塞体积。此外,通过免疫组织化学,蛋白质印迹和RT-qPCR方法分析了Akt,CREB,BDNF,Bcl-2和claudin-5在缺血性大脑皮层中的活性。与媒介物组相比,NOB-H组的神经功能缺损和脑水肿得到缓解(P <0.05),NOB-L和NOB-H组的脑梗死体积在卒中后24 h均减轻(P <0.05)。免疫组化,Western印迹和RT-qPCR分析表明,NOB显着促进Akt,CREB,BDNF和Bcl-2的活性(P <0.05)。同时,claudin-5表达也得到增强。根据这些发现,我们得出结论,NOB可以通过激活Akt / CREB信号通路和改善BBB通透性来保护大脑免受缺血性损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号